Drug intelligence / Profile preview

Bismu-Jet

Development stage
Phase 3
Lead developer
EMS
Modality
Small Molecules
Administration
Topical
01

Overview

**Bismu-Jet** is a Brazilian fixed-dose topical oral suspension for adjunctive treatment of oral mucosal conditions, including aphthous ulcerations. It contains neomycin sulfate, bismuth sodium tartrate, and procaine hydrochloride. Neomycin provides local antibacterial activity through inhibition of bacterial protein synthesis; bismuth sodium tartrate is described in the product information as bactericidal; and procaine provides local anesthetic analgesia at the inflamed oral site. The marketed presentation is a 20 mL dropper bottle containing 25 mg/mL neomycin sulfate, 25 mg/mL bismuth sodium tartrate, and 15 mg/mL procaine hydrochloride, for topical application in the mouth. ([img.drogasil.com.br](https://img.drogasil.com.br/raiadrogasil_bula/Bismu-Jet.pdf))

Brand names
Bismu-Jet
Other names
bismuth sodium tartrate + neomycin sulfate + procaine hydrochloridecloridrato de procaína + sulfato de neomicina + tartarato de bismuto e sódio
02

Targets

NaV (Voltage-gated sodium channels)Bacterial Ribosome

Beyond the preview

Go deeper on Bismu-Jet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bismu-Jet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call